Cholecystokinin and opiate interactions.

Cholecystokinin-dopamine interactions.

A model for opiate-receptor interactions: mechanism of opiate-cerebroside sulfate interaction.

Morphine-like peptides in mammalian brain: isolation, structure elucidation, and interactions with the opiate receptor.

Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors.

Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity.

Opiate receptor blockade in juvenile macaques: effect on affiliative interactions with their mothers and group companions.

Clonidine and opiate withdrawal.

Cholecystokinin and gastrointestinal cancer.

The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.

Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat.

Interactions of peptides derived from the C-fragment of beta-lipotropin with brain opiate receptors [proceedings].

Cholecystokinin cholecystography.

Cholecystokinin antagonists.

The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats.

Clonidine in opiate withdrawal.

New opiate-receptor model.

Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal.

Opiate and non-opiate mechanisms of stress-induced analgesia: cross-tolerance between stressors.

The opiate receptor.

Genetics of opiate addiction.

Neurobiology of opiate abuse.

The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists.

2-Deoxy-D-glucose analgesia: influences of opiate and non-opiate factors.

The measurement of cholecystokinin.

Suggest Documents

Cholecystokinin-dopamine interactions.

A model for opiate-receptor interactions: mechanism of opiate-cerebroside sulfate interaction.

Morphine-like peptides in mammalian brain: isolation, structure elucidation, and interactions with the opiate receptor.

Interactions of chloroquine with benzodiazepine, gamma-aminobutyric acid and opiate receptors.

Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity.

Opiate receptor blockade in juvenile macaques: effect on affiliative interactions with their mothers and group companions.

Clonidine and opiate withdrawal.

Cholecystokinin and gastrointestinal cancer.

The opiate receptor binding interactions of 3H-methionine enkephalin, an opioid peptide.

Opiate-dopamine interactions in the neural substrates of acoustic startle gating in the rat.

Interactions of peptides derived from the C-fragment of beta-lipotropin with brain opiate receptors [proceedings].

Cholecystokinin cholecystography.

Cholecystokinin antagonists.

The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats.

Clonidine in opiate withdrawal.

New opiate-receptor model.

Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal.

Opiate and non-opiate mechanisms of stress-induced analgesia: cross-tolerance between stressors.

The opiate receptor.

Genetics of opiate addiction.

Neurobiology of opiate abuse.

The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists.

2-Deoxy-D-glucose analgesia: influences of opiate and non-opiate factors.

The measurement of cholecystokinin.

Cholecystokinin and opiate interactions.

Recommend Documents

Follow Us